VNDA

Vanda Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality7/10
  • Growth↓ 0/10
  • Momentum↑ 9/10
Vanda Pharmaceuticals sales and earnings growth
VNDA Growth
Low
  • Revenue Y/Y↑ 8.72%
  • EPS Y/Y↓ -1033.33%
  • FCF Y/Y↓ -579.76%
Vanda Pharmaceuticals gross and profit margin trends
VNDA Profitability
Fair
  • Gross margin ↑ 94.00%
  • EPS margin↓ -102.00%
  • ROIC↓ -50.90%
Vanda Pharmaceuticals net debt vs free cash flow
VNDA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Vanda Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗